scholarly journals Pharmaceutical product cross-contamination: industrial and clinical pharmacy practice

2013 ◽  
Vol 19 (2) ◽  
Author(s):  
E Mathia
Keyword(s):  
Clinical Pharmacy ◽  
Pharmacy Practice ◽  
Pharmaceutical Product ◽  
Cross Contamination

Proposed guidance on cost-avoidance studies in pharmacy practice

2021 ◽  
Author(s):  
Asad E Patanwala ◽  
Sujita W Narayan ◽  
Curtis E Haas ◽  
Ivo Abraham ◽  
Arthur Sanders ◽  
...  
Keyword(s):  
Clinical Pharmacy ◽  
Best Practice ◽  
Pharmacoeconomic Analysis ◽  
Pharmacy Practice ◽  
Cost Savings ◽  
Sensitivity Analyses ◽  
Cost Assessment ◽  
Potential Consequence ◽  
Cost Avoidance ◽  
Pharmacist Interventions

Abstract Disclaimer In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. Purpose Cost-avoidance studies of pharmacist interventions are common and often the first type of study conducted by investigators to quantify the economic impact of clinical pharmacy services. The purpose of this primer is to provide guidance for conducting cost-avoidance studies pertaining to clinical pharmacy practice. Summary Cost-avoidance studies represent a paradigm conceptually different from traditional pharmacoeconomic analysis. A cost-avoidance study reports on cost savings from a given intervention, where the savings is estimated based on a counterfactual scenario. Investigators need to determine what specifically would have happened to the patient if the intervention did not occur. This assessment can be fundamentally flawed, depending on underlying assumptions regarding the pharmacists’ action and the patient trajectory. It requires careful identification of the potential consequence of nonaction, as well as probability and cost assessment. Given the uncertainty of assumptions, sensitivity analyses should be performed. A step-by-step methodology, formula for calculations, and best practice guidance is provided. Conclusions Cost-avoidance studies focused on pharmacist interventions should be considered low-level evidence. These studies are acceptable to provide pilot data for the planning of future clinical trials. The guidance provided in this article should be followed to improve the quality and validity of such investigations.

scholarly journals Accountable Clinical Pharmacy Practice

2004 ◽  
Vol 34 (4) ◽  
pp. 258-259 ◽  
Author(s):  
Penny Thornton
Keyword(s):  
Clinical Pharmacy ◽  
Pharmacy Practice

Cardiology, Clinical Pharmacy Practice in

2002 ◽  
pp. 119-126
Author(s):  
Mary Southworth ◽  
Jerry Bauman
Keyword(s):  
Clinical Pharmacy ◽  
Pharmacy Practice

scholarly journals Redesign of the Clinical Pharmacy Practice Model in a Tertiary Academic Hospital in Medellín, Colombia

2017 ◽  
Vol 70 (3) ◽  
Author(s):  
Juan Pablo Botero Aguirre ◽  
Andrés Felipe Valencia Quintero ◽  
Elkyn Johan Granados Vega
Keyword(s):  
Clinical Pharmacy ◽  
Pharmacy Practice ◽  
Academic Hospital ◽  
Practice Model

-

scholarly journals Redesigning the advanced pharmacy practice experiential education from hospital to home: A COVID-19 scenario

2021 ◽  
pp. 212-220
Author(s):  
Jisha Myalil Lucca ◽  
Dana Muwafag Alsugeir ◽  
Bashayer Mohmmed Al Shehail ◽  
Veerendra Chandralla ◽  
Dhafer Mahdi Alshayban ◽  
...  
Keyword(s):  
Learning Outcomes ◽  
Experiential Education ◽  
Clinical Pharmacy ◽  
Student Assessment ◽  
Pharmacy Practice ◽  
Assessment Method ◽  
Online Questionnaire ◽  
Experiential Training ◽  
Virtual Platform ◽  
Case Presentations

Introduction: During the 2020 COVID-19 pandemic, suspension of many educational activities occurred to mitigate the risks of infection spread. For pharmacy students in their internship year, many efforts have been made to move their experiential training to a virtual platform without compromising learning outcomes. Objectives: Redesign the advanced pharmacy practice experience (APPE) to remote learning without compromising the learning outcomes; Develop an appropriate teaching modality/strategy and assessment method for remote APPE; To drive the change in experiential education by providing guidance for other pharmacy schools dealing with similar situations. Restructured APPE: Eighty-seven interns were switched to an online internship with five specialties based on the availability of the preceptors, namely internal medicine, infectious diseases, oncology, total parenteral nutrition, and psychiatry. Experiential education activities such as drug information questions, case presentations, and clinical pharmacy topic discussions took place on virtual platforms. Student assessment was done using adjusted rubrics to suit the online platforms. Student feedback was taken using an online questionnaire and was mostly positive, indicating that they improved their clinical pharmacy knowledge. Conclusion: The authors highlighted the various restructuring modalities and learning methods used for different clinical rotations to achieve the learning outcomes in difficult situations. In future, the authors plan to work with their colleagues in other health colleges to adapt their practices together.

scholarly journals Clinical pharmacy practice in the care of Chronic Kidney Disease patients: a systematic review

2019 ◽  
Vol 41 (3) ◽  
pp. 630-666 ◽  
Author(s):  
Fatma Al Raiisi ◽  
Derek Stewart ◽  
Fernando Fernandez-Llimos ◽  
Teresa M. Salgado ◽  
Moustafa Fahmy Mohamed ◽  
...  
Keyword(s):  
Systematic Review ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Clinical Pharmacy ◽  
Pharmacy Practice
Sign in / Sign up

Export Citation Format

Share Document